SGLT2 inhibitors as potentially helpful drugs in PI3K inhibitor-induced diabetes: a case report.

Nicolas SahakianLauranne CattieuwClotilde Ramillon-CuryAudrey Bégu-Le CorrollerPascale Silvestre-AillaudSophie BéliardRené Valéro

Published in: Clinical diabetes and endocrinology (2021)

We report the successful management of hyperglycemia induced by alpelisib using a SGLT2 inhibitor without the need to discontinue effective cancer treatment.

Keyphrases

diabetic rats
type diabetes
cardiovascular disease
high glucose
drug induced
glycemic control
oxidative stress
endothelial cells
adipose tissue
stress induced